Agreement aims to expand antibiotic access in poor countries

"It's significant for a company that has little presence in low- and middle-income countries, like Shionogi, to enter into an arrangement like this," the author writes, quoting Jayasree K. Iyer, CEO of the Access to Medicine Foundation. 

The article follows the publication of our report, Lack of access to medicine is a major driver of drug resistance. How can pharma take action?, which includes a case study of the partnership.